Lynx1 Capital Management LP

Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 7,857,347 shares
Security Ownership %: 15%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

14 Aug 2025 - Lynx1 Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,857,347 shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX). This represents 15% ownership of the company. In their previous filing dated 14 Feb 2025, Lynx1 Capital Management LP had reported owning 5,357,347 shares, indicating an increase of +47%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Lynx1 Capital Management LP	15%	+37%	$11,393,153	7,857,347	+2,500,000	+47%	$1.45	13G/A	30 Jun 2025	14 Aug 2025, 07:06
Lynx1 Capital Management LP	11%		$8,571,755	5,357,347			$1.60	13G/A	31 Dec 2024	14 Feb 2025, 09:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.6%	+0.03%	$8,019,148	8,019,148	+161,801	+2.1%	$1.00	Q4 2025
30 Sep 2025	2.9%	0%	$14,300,372	7,857,347	0		$1.82	Q3 2025
30 Jun 2025	3.3%	+1%	$11,393,153	7,857,347	+2,500,000	+47%	$1.45	Q2 2025
31 Mar 2025	2.6%	0%	$7,393,139	5,357,347	0		$1.38	Q1 2025
31 Dec 2024	6.1%	+0.15%	$16,286,335	5,357,347	+132,747	+2.5%	$3.04	Q4 2024
30 Sep 2024	9.2%	0%	$26,018,508	5,224,600	0		$4.98	Q3 2024
30 Jun 2024	11%	0%	$30,563,910	5,224,600	0		$5.85	Q2 2024
31 Mar 2024	11%	0%	$41,483,324	5,224,600	0		$7.94	Q1 2024
31 Dec 2023	12%	0%	$30,459,418	5,224,600	0		$5.83	Q4 2023
30 Sep 2023	8.8%	0%	$13,374,976	5,224,600	0		$2.56	Q3 2023
30 Jun 2023	8.6%	+8.6%	$13,061,500	5,224,600	+5,224,600	NEW	$2.50	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.